The joint EURETINA, ESCRS, EuCornea, and ESONT meetings, plus several related conferences, were held September 11 to 17.
Total retinal procedure volume rose 4.9 percent over Q2-2013’s tally and 2.5 percent over the total in Q1-2014.
Researchers reviewed nine clinical trials and found the risk of death or serious adverse events was similar for the anti-VEGFs.
The market is expected to total $3.2 billion by 2019.
Auxilium said it would not abandon its acquisition deal with Canadian ophthalmic company.
The deal is expected to increase BVI’s participation in glaucoma and retinal surgery.
WaveTec sells the ORA System, an intraoperative guidance system for cataract surgeons implanting IOLs.
Valeant will distribute the ophthalmic brands in Western Europe and seek approvals for marketing them in the US.
The maker of Restasis appears to be looking for options ahead of a shareholders’ meeting set for December.
You are not currently logged in.
©2017 Market Scope
Lost your Password